TCM
MGNX icon

Tanaka Capital Management’s MacroGenics MGNX Stock Holding History

Tanaka Capital Management’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-16,720
Closed -$311K – 53
2017
Q1 		$311K Sell
16,720
-8,530
-34% -$165K 0.69% 29
2016
Q4 		$516K Sell
25,250
-920
-4% -$23.2K 1.21% 27
2016
Q3 		$783K Hold
26,170
– – 1.88% 19
2016
Q2 		$706K Hold
26,170
– – 1.81% 20
2016
Q1 		$491K Buy
26,170
+570
+2% +$10.9K 1.11% 26
2015
Q4 		$793K Buy
+25,600
New +$778K 1.71% 23

Other funds holding MGNX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Tanaka Capital Management's MGNX Position: Q2 2017 in Review

Tanaka Capital Management sold out of MacroGenics (MGNX) in Q2 2017, closing a stake of 16,720 shares — an estimated $311K sold.

Tanaka Capital Management first reported a position in MGNX in Q4 2015 and held it in 6 quarters. The position peaked at $793K in Q4 2015. 113 funds tracked by Wall St. Rank hold MGNX as of Q2 2017.

  • Tanaka Capital Management reported no remaining MacroGenics position as of Q2 2017 after selling out during the quarter.
  • Tanaka Capital Management sold 16,720 MacroGenics shares in Q2 2017, an estimated $311K.
  • Tanaka Capital Management first reported a position in MacroGenics in Q4 2015 and held it in 6 quarters.
  • Tanaka Capital Management's MacroGenics position peaked at $793K in Q4 2015.
  • 113 funds tracked by Wall St. Rank held MacroGenics as of Q2 2017.

Based on Tanaka Capital Management's 13F filing for Q2 2017, filed 15 Aug 2017.